PL3288933T3 - Związki oksindolowe i ich kompozycje farmaceutyczne - Google Patents
Związki oksindolowe i ich kompozycje farmaceutyczneInfo
- Publication number
- PL3288933T3 PL3288933T3 PL16787128T PL16787128T PL3288933T3 PL 3288933 T3 PL3288933 T3 PL 3288933T3 PL 16787128 T PL16787128 T PL 16787128T PL 16787128 T PL16787128 T PL 16787128T PL 3288933 T3 PL3288933 T3 PL 3288933T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- oxindole compounds
- oxindole
- compounds
- pharmaceutical
- Prior art date
Links
- 125000004095 oxindolyl group Chemical class N1(C(CC2=CC=CC=C12)=O)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562155019P | 2015-04-30 | 2015-04-30 | |
| EP16787128.4A EP3288933B1 (en) | 2015-04-30 | 2016-04-28 | Oxindole compounds and pharmaceutical compositions thereof |
| PCT/US2016/029726 WO2016176420A1 (en) | 2015-04-30 | 2016-04-28 | Oxindole compounds and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3288933T3 true PL3288933T3 (pl) | 2022-03-21 |
Family
ID=57198764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16787128T PL3288933T3 (pl) | 2015-04-30 | 2016-04-28 | Związki oksindolowe i ich kompozycje farmaceutyczne |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10370328B2 (pl) |
| EP (1) | EP3288933B1 (pl) |
| JP (3) | JP2018514572A (pl) |
| AU (1) | AU2016254049A1 (pl) |
| CA (1) | CA2982824C (pl) |
| DK (1) | DK3288933T3 (pl) |
| ES (1) | ES2898922T3 (pl) |
| PL (1) | PL3288933T3 (pl) |
| PT (1) | PT3288933T (pl) |
| WO (1) | WO2016176420A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3852754A4 (en) * | 2018-09-18 | 2022-06-15 | 1Globe Biomedical Co., Ltd. | TREATMENT OF OBESITY |
| CN113979869B (zh) * | 2021-11-26 | 2024-04-30 | 赣南师范大学 | 一种二氟苄基化试剂及其制备方法和应用 |
| WO2023250374A1 (en) * | 2022-06-21 | 2023-12-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating renal disease |
| CN119798230B (zh) * | 2025-03-13 | 2025-06-27 | 中国药科大学 | 吲哚酮类化合物及其在治疗急慢性肝病与促进组织修复中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1155572C (zh) * | 2001-01-19 | 2004-06-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 吲哚类衍生物及其抗肿瘤用途 |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| EP1696906A1 (en) * | 2003-12-16 | 2006-09-06 | Leo Pharma A/S | Novel therapeutic use of indolinone derivatives |
| EP2479168B1 (en) | 2004-02-25 | 2014-04-09 | Eli Lilly And Company | 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists |
| WO2006032164A1 (en) * | 2004-09-23 | 2006-03-30 | Beijing Molecule Science And Technology Co., Ltd. | 1,3-substitued-2-indolinone derivatives, the preparation, the composition and the use thereof |
| WO2006105795A1 (en) * | 2005-04-08 | 2006-10-12 | Leo Pharma A/S | Novel indolinone derivatives |
| AR056317A1 (es) * | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| US20110124634A1 (en) | 2008-05-13 | 2011-05-26 | Poniard Pharmaceuticals, Inc. | Bioactive compounds for treatment of cancer and neurodegenerative diseases |
| JP2011001309A (ja) * | 2009-06-19 | 2011-01-06 | Gifu Univ | オキシインドール誘導体及び神経細胞死抑制剤 |
| EP2550260A1 (en) * | 2010-03-24 | 2013-01-30 | Medical University Of South Carolina | Compositions and methods for the treatment of degenerative diseases |
| JP5937102B2 (ja) * | 2010-12-14 | 2016-06-22 | エレクトロフォレティクス リミテッド | カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤 |
| HRP20171665T1 (hr) | 2011-12-28 | 2017-12-15 | Global Blood Therapeutics, Inc. | Supstituirani spojevi benzaldehida i metode za njihovu primjenu u povećanju oksigenacije tkiva |
| WO2014074976A1 (en) * | 2012-11-09 | 2014-05-15 | Musc Foundation For Research Development | Compositions and methods for treating neurological diseases or injury |
| US20140275178A1 (en) * | 2013-03-13 | 2014-09-18 | Musc Foundation For Research Development | Thiazole compounds, compositions and methods for treatment of degenerative diseases and disorders |
| US9079853B2 (en) * | 2013-02-07 | 2015-07-14 | Musc Foundation For Research Development | Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders |
| KR101432427B1 (ko) * | 2013-02-20 | 2014-09-02 | 영남대학교 산학협력단 | 요오드 촉매를 이용한 3-하이드록시-2-옥신돌 유도체의 효율적 합성방법 |
| WO2020091119A1 (ko) | 2018-11-02 | 2020-05-07 | 엘지전자 주식회사 | 차량용 전자 장치, 차량용 전자 장치의 동작 방법 및 시스템 |
-
2016
- 2016-04-28 JP JP2017557113A patent/JP2018514572A/ja not_active Withdrawn
- 2016-04-28 AU AU2016254049A patent/AU2016254049A1/en not_active Abandoned
- 2016-04-28 DK DK16787128.4T patent/DK3288933T3/da active
- 2016-04-28 WO PCT/US2016/029726 patent/WO2016176420A1/en not_active Ceased
- 2016-04-28 CA CA2982824A patent/CA2982824C/en active Active
- 2016-04-28 PT PT167871284T patent/PT3288933T/pt unknown
- 2016-04-28 ES ES16787128T patent/ES2898922T3/es active Active
- 2016-04-28 PL PL16787128T patent/PL3288933T3/pl unknown
- 2016-04-28 EP EP16787128.4A patent/EP3288933B1/en active Active
- 2016-04-28 US US15/565,820 patent/US10370328B2/en active Active
-
2019
- 2019-09-27 JP JP2019177319A patent/JP6820072B2/ja active Active
-
2020
- 2020-12-24 JP JP2020215002A patent/JP7091437B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020019786A (ja) | 2020-02-06 |
| AU2016254049A1 (en) | 2017-11-02 |
| JP6820072B2 (ja) | 2021-01-27 |
| EP3288933A1 (en) | 2018-03-07 |
| US20180134659A1 (en) | 2018-05-17 |
| PT3288933T (pt) | 2021-11-29 |
| WO2016176420A1 (en) | 2016-11-03 |
| EP3288933A4 (en) | 2019-01-16 |
| CA2982824A1 (en) | 2016-11-03 |
| US10370328B2 (en) | 2019-08-06 |
| JP2018514572A (ja) | 2018-06-07 |
| CA2982824C (en) | 2023-11-21 |
| JP2021059578A (ja) | 2021-04-15 |
| ES2898922T3 (es) | 2022-03-09 |
| JP7091437B2 (ja) | 2022-06-27 |
| EP3288933B1 (en) | 2021-10-06 |
| DK3288933T3 (da) | 2021-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265260B (en) | pharmaceutical preparations | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| IL265360A (en) | Pharmaceutical composition | |
| IL262654A (en) | Pharmacy preparation | |
| SI3426348T1 (sl) | Derivat 3-dezoksi in njegovi farmacevtski sestavki | |
| IL249803A0 (en) | History of azafenil and pharmaceutical preparations containing them | |
| IL265349A (en) | Pharmaceutical composition | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| PL3288933T3 (pl) | Związki oksindolowe i ich kompozycje farmaceutyczne | |
| PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| IL255510A (en) | Pharmaceutical compositions | |
| IL254711B (en) | History of diazepine-indole and medicinal preparations containing them | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| IL263999A (en) | Pharmaceutical compositions | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| IL265436B (en) | Pharmacy preparation | |
| ZA201705782B (en) | Pharmaceutical compositions | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| IL265428A (en) | Pharmaceutical composition | |
| ZA201705783B (en) | Pharmaceutical compositions |